Biodesix, Inc.
BDSX
$15.90
$0.684.47%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 29.05% | 24.08% | 22.29% | 25.70% | 35.76% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 29.05% | 24.08% | 22.29% | 25.70% | 35.76% |
| Cost of Revenue | 9.44% | 7.36% | 10.80% | 19.04% | 23.70% |
| Gross Profit | 34.46% | 28.75% | 25.58% | 27.63% | 39.51% |
| SG&A Expenses | 13.71% | 8.82% | 10.86% | 15.47% | 16.52% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 13.63% | 10.12% | 12.38% | 17.45% | 17.73% |
| Operating Income | 21.84% | 18.96% | 6.41% | -2.27% | 9.83% |
| Income Before Tax | 20.93% | 17.86% | 9.77% | 7.71% | 14.11% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 20.93% | 17.86% | 9.77% | 7.71% | 14.11% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 20.93% | 17.86% | 9.77% | 7.71% | 14.11% |
| EBIT | 21.84% | 18.96% | 6.41% | -2.27% | 9.83% |
| EBITDA | 25.98% | 22.43% | 9.04% | 1.66% | 16.78% |
| EPS Basic | 29.95% | 32.57% | 31.86% | 39.19% | 47.41% |
| Normalized Basic EPS | 28.40% | 32.03% | 31.62% | 39.03% | 48.00% |
| EPS Diluted | 29.95% | 32.57% | 31.86% | 39.19% | 47.41% |
| Normalized Diluted EPS | 28.40% | 32.03% | 31.62% | 39.03% | 48.00% |
| Average Basic Shares Outstanding | 15.02% | 16.77% | 27.28% | 47.73% | 62.80% |
| Average Diluted Shares Outstanding | 15.02% | 16.77% | 27.28% | 47.73% | 62.80% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |